1. ABOUT US

    #

    about us

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  2. RESEARCH REPORTS

    RESEARCH REPORTS

    RESEARCH REPORTS

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
  3. METHODOLOGY

    #

    METHODOLOGY

    Azoth Analytics creates in-depth research reports by recording, interpreting and analyzing information through primary and secondary research. Our strategic market sizing and data dredging techniques include secondary research, interviews with key market players and industry experts and use of industry specific statistical tools which helps in designing and planning effective research for our global and local clients.

    Read More
  4. Consulting

    #

    Consulting

    Azoth Analytics Consulting assists clients across the globe to enter, progress, and develop in the targeted market through our fact-based business intelligence. We deliver practical and implementable solutions to our domestic and international clients. Our analysts are skilled with techniques of data gathering, market sizing, forecasting, analyzing and providing competitive intelligence and provide progressive research in verticals including healthcare & pharmaceutical...

    Read More
  5. media center

    #

    media center

    Our business research and market analysis helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

    Read More
news

     Home >> Research Report >> Healthcare & Pharma >> Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)
 

Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025) -.

 
Publish Date:July 2020
No. of Pages:180
Format: Pdf (Instant Download)
 
 
Social
Electronic Access - Single User License toll
$1800
 
Electronic Access - Multi User License toll
$2400
 
Hard Copy Mail Delivery toll
$2000
 
 
Executive Summary

Global Psoriasis Treatment Market was valued at USD 16.7 billion in the year 2019. Rising prevalence of psoriasis affected people, rise in research and investments in developing biological treatment, rise in awareness of psoriasis coupled with the rising demand for healthcare products are the major factors impelling the market growth. Major growth in the forecast period is likely to be demonstrated from the various drugs that are in the clinical stages and would be available commercially in the next 3-5 years. This includes among others, the most promising ARQ-154 Foam for scalp psoriasis, from the US biotechnology company, Arcutis, which has the potential to become a billion-dollar opportunity for the treatment of psoriasis.

Genetic disposition, rising geriatric population and increasing government initiatives creating psoriasis awareness have been anticipated to infuse growth in the market for Psoriasis during the forecasting period of 2020-2025. Factors such as rising geriatric population, practice of unhealthy lifestyle such as heavy consumption of alcohol, smoking tobacco, enaction of immunity framework, stress and sunburn are crucial factors are supposed to trigger Psoriasis and Psoriasis arthritis that is consequently accelerating the demand for Psoriasis treatment and medication. The growth of the market is hampered in 2020 due to the occurrence of coronavirus pandemic in which all worldwide business activities are put at hold for the first few months of the year. IPC recommended physicians to discontinue or postpone use of immunosuppressant medications for the psoriasis patients, which is negatively affecting the Psoriasis drugs market growth. However, as per National Psoriasis Foundation the Medicare extended its inclusion of tele-health administrations in amid COVID-19 pandemic due to which the treatment has been resumed and the drug market has been supported in few first few months of 2020 that are anticipated to recover and accelerate the demand for the treatment in the coming years.

Under the Type Segment, Plaque Psoriasis is the most common type of psoriasis and dominates the overall psoriasis market. The developing number of advanced medicines for the treatment of plaque psoriasis by the key players is augmenting the demand for enhanced medication. 

The continual research and development in a number of biologics and biosimilars by the drug developing companies are expected to propel market demand of biologics treatment method for psoriasis. Among the regions, North America is followed by and Europe and Asia Pacific. Asia Pacific region is the most attractive region for the growth of Psoriasis treatment owing large targeted population base coupled with increasing healthcare spending, prevalence of psoriasis or psoriatic arthritis patients, rise in government contribution and awareness programs.

Scope of the Report

• The report analyses Psoriasis market By Value. 
• The report analyses Psoriasis Market By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis). 
• The report assesses the Psoriasis market By Treatment Method – (Biologics, Systemic Treatment, Topical Treatment, Others).
• The Global Psoriasis Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (US, Canada, Norway, UK, Spain, Germany, China, India, South Korea, Japan).
• The key insights of the report have been presented through the attractiveness of the market has been presented By Type, By Treatment Method and By Region. Additionally, the major opportunities, trends, drivers, challenges and pipeline products of the industry has been analysed in the report. 
• The companies analysed in the report include UCB, Sun Pharmaceutical Industries LTD, Boehringer Ingelheim, Almirall, Bausch Health, Abbvie Inc, Eli Lilly and Company, Pfizer Inc., Amgen Inc., Johnson & Johnson. 
• The report presents the analysis of Psoriasis market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience

• AD and Psoriasis Drug Developers
• Pharmaceutical and Biotechnology Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Investment Banks and Equity Firms
• Regulatory Authorities
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations

3. Global Psoriasis Treatment Market: Product Outlook

4. Global Psoriasis Treatment Market: Sizing, Growth and Forecast
4.1 Market Size, By Value, Year 2015-2025

5. Global Psoriasis Treatment Market Segmentation By Type (By Value)
5.1  Competitive Scenario of Global Psoriasis Market – By Type (2019 & 2025)
5.2 Plaque Psoriasis– Market Size and Forecast (2020-2025)
5.3 Inverse Psoriasis– Market Size and Forecast (2020-2025)
5.4 Guttate Psoriasis- Market Size and Forecast (2020-2025)
5.5 Pustular Psoriasis- Market Size and Forecast (2020-2025)
5.6 Erythrodermic Psoriasis- Market Size and Forecast (2020-2025)

6. Global Psoriasis Market Segmentation By Treatment Method (By Value)
6.1 Competitive Scenario of Global Psoriasis – By Treatment Method (2019 & 2025)
6.2 Biologics – Market Size and Forecast (2020-2025)
6.3 Systemic Treatment– Market Size and Forecast (2020-2025)
6.4 Topical Treatment– Market Size and Forecast (2020-2025)
6.5 Others – Market Size and Forecast (2020-2025)

7. Global Psoriasis Treatment Market: Regional Analysis
7.1 Competitive Scenario of Global Psoriasis Market : By Region (2019 & 2025)

8. North America Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
8.1 North America Psoriasis Treatment Market: Size and Forecast (2020-2025)
8.2 North America Prominent Companies in Psoriasis Market
8.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
8.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)

8.5 North America Psoriasis Market: Country Analysis
8.6 Market Opportunity Chart of North America Psoriasis Market - By Country, By Value (Year-2025)
8.7 Competitive Scenario of North America Psoriasis Market: By Country (2019 & 2025)
8.8 United States Psoriasis Market: Size and Forecast (2020-2025)
8.9 United States Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
8.10 Canada  Psoriasis Market: Size and Forecast (2020-2025)
8.11 Canada  Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)

9. Europe Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
9.1 Europe Psoriasis Treatment Market: Size and Forecast (2020-2025)
9.2 Europe Prominent Companies in Psoriasis Market
9.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
9.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)

9.5 Europe Psoriasis Market: Country Analysis
9.6 Market Opportunity Chart of Europe Psoriasis Market - By Country, By Value (Year-2025)
9.7 Competitive Scenario of Europe Psoriasis Market: By Country (2019 & 2025)
9.8 Norway Psoriasis Market: Size and Forecast (2020-2025)
9.9 Norway Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
9.10 United Kingdom Psoriasis Market: Size and Forecast (2020-2025)
9.11 United Kingdom Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
9.12 Spain Psoriasis Market: Size and Forecast (2020-2025)
9.13 Spain Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
9.14 Germany Psoriasis Market: Size and Forecast (2020-2025)
9.15 Germany Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)

10. Asia Pacific Psoriasis Market: Segmentation By Type, By Treatment Method (2020-2025)
10.1 Asia Pacific Psoriasis Treatment Market: Size and Forecast (2020-2025)
10.2 Asia Pacific Prominent Companies in Psoriasis Market
10.3 Market Segmentation By Type (Plaque Psoriasis, Inverse Psoriasis, Guttate Psoriasis, Pustular Psoriasis- & Erythrodermic Psoriasis)
10.4 Market Segmentation By Treatment Method (Biologics, Systemic Treatment, Topical Treatment & Others)

10.5 Asia Pacific Psoriasis Market: Country Analysis
10.6 Market Opportunity Chart of Asia Pacific Psoriasis Market - By Country, By Value (Year-2025)
10.7 Competitive Scenario of Asia Pacific Psoriasis Market: By Country (2019 & 2025)
10.8 China Psoriasis Market: Size and Forecast (2020-2025)
10.9 China Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
10.10 India Psoriasis Market: Size and Forecast (2020-2025)
10.11 India Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
10.12 South Korea Psoriasis Market: Size and Forecast (2020-2025)
10.13 South Korea Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)
10.14 Japan Psoriasis Market: Size and Forecast (2020-2025)
10.15 Japan Psoriasis Market Segmentation By Type, By Treatment Method (2020-2025)

11. Global Psoriasis Treatment Market Dynamics
11.1 Global Psoriasis  Market Drivers
11.2 Global Psoriasis Market Restraints
11.3 Global Psoriasis Market Trends

12. Market Attractiveness
12.1.1 Market Attractiveness Chart of Global Psoriasis Treatment Market - By Type (Year 2025)
12.1.2 Market Attractiveness Chart of Global Psoriasis Market - By Treatment Method (Year 2025)
12.1.3 Market Attractiveness Chart of Global Psoriasis Treatment Market - By Region, By Value, (Year-2025)

13. Competitive Landscape
13.1 Psoriasis Pipeline Analysis
13.2 Market Share Analysis

14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 UCB
14.2 Sun Pharmaceutical Industries LTD 
14.3 Boehringer Ingelheim 
14.4 Almirall
14.5 Bausch Health
14.6 Abbvie Inc
14.7 Eli Lilly and Company 
14.8 Pfizer Inc.
14.9 Amgen Inc
14.10 Johnson & Johnson

List of Figures

Figure 1: Global Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Figure 3: Obese Population, By Country, 2017 (In Millions)
Figure 4: Global Aged Population (Above 65), 2013-2017 (% of total)
Figure 5: Global Aged Population(Above 65), By Country, 2017 (% of total)
Figure 6: Global Health Expenditure, (% of GDP), 2014-2017 
Figure 7: Global Population Ages 65 and Above (% of total), 2015-2019
Figure 8: Global Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 9: Global Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 10: Global Psoriasis Treatment Market- By Type (2019 & 2025)
Figure 11: Global Psoriasis Market- By Plaque Psoriasis, By Value (USD Million), 2015-2025
Figure 12: Global Psoriasis Market- By Inverse Psoriasis, By Value (USD Million), 2015-2025
Figure 13: Global Psoriasis Market- By Guttate Psoriasis, By Value (USD Million), 2015-2025
Figure 14: Global Psoriasis Market- By Pustular Psoriasis, By Value (USD Million), 2015-2025
Figure 15: Global Psoriasis Market- By Erythrodermic Psoriasis, By Value (USD Million), 2015-2025
Figure 16: Global Psoriasis Market- By Treatment Method (2019 & 2025)
Figure 17: Global Psoriasis Market- By Biologics, By Value (USD Million), 2015-2025
Figure 18: Global Psoriasis Market- By Systemic Treatment, By Value (USD Million), 2015-2025
Figure 19: Global Psoriasis Market- By Topical Treatment, By Value (USD Million), 2015-2025
Figure 20: Global Psoriasis Market- By Others, By Value (USD Million), 2015-2025
Figure 21: Global Psoriasis Market- By Region (2019 & 2025)
Figure 22: North America Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 23: North America, Health Expenditure, (% of GDP), 2014-2017 
Figure 24: North America Population Ages 65 and Above (% of total), 2015-2019
Figure 25: North America Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 26: North America, Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 27: North America Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 28: North America Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 29: Market Opportunity Chart of North America Psoriasis Market - By Country, By Value (Year-2025)
Figure 30: North America Psoriasis Market- By Country (2019 & 2025)
Figure 31: United States Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 32: United States, Health Expenditure, (% of GDP), 2014-2017 
Figure 33:  United States Population Ages 65 and Above (% of total), 2015-2019
Figure 34: United States Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 35: United States, Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 36: United States Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 37: United States Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 38: Canada Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 39: Canada, Health Expenditure, (% of GDP), 2014-2017 
Figure 40: Canada Population Ages 65 and Above (% of total), 2015-2019
Figure 41: Canada Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 42: Canada, Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 43: Canada Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 44: United States Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 45: Europe Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 46: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 47: European Union, Health Expenditure, (% of GDP), 2014-2017 
Figure 48: European Union Population Ages 65 and Above (% of total), 2015-2019
Figure 49: European Union Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 50: European Union, Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 51: Europe Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 52: Europe Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 53: Market Opportunity Chart of Psoriasis Market - By Country, By Value (Year-2025)
Figure 54: Europe Psoriasis Market- By Country (2019 & 2025)
Figure 55: Norway Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 56: Norway Health Expenditure, (% of GDP), 2014-2017 
Figure 57: Norway Population Ages 65 and Above (% of total), 2015-2019
Figure 58: Norway Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 59: Norway Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 60: Norway Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 61: Norway Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 62: United Kingdom Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 63: United Kingdom Health Expenditure, (% of GDP), 2014-2017 
Figure 64: United Kingdom Population Ages 65 and Above (% of total), 2015-2019
Figure 65: United Kingdom Prevalence of Psoriasis, 2014-2017 (In Millions)
Figure 66: United Kingdom Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 67: United Kingdom Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 68: United Kingdom Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 69: Spain Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 70: Spain, Health Expenditure, (% of GDP), 2014-2017 
Figure 71: Spain Population Ages 65 and Above (% of total), 2015-2019
Figure 72: Spain Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 73: Spain Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 74: Spain Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 75: Spain Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 76: Germany Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 77: Germany Health Expenditure, (% of GDP), 2014-2017 
Figure 78: Germany Population Ages 65 and Above (% of total), 2015-2019
Figure 79: Germany Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 80: Germany Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 81: Germany Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 82: Germany Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 83: Asia Pacific Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 84: Asia Pacific Health Expenditure, (% of GDP), 2014-2017 
Figure 85: Asia Pacific Population Ages 65 and Above (% of total), 2015-2019
Figure 86: Asia Pacific Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 87: Asia Pacific Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 88: Asia Pacific Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 89: Asia Pacific Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 90: Market Opportunity Chart of Asia Pacific Psoriasis Market - By Country, By Value (Year-2025)
Figure 91: Asia Pacific Psoriasis Market- By Country (2019 & 2025)
Figure 92: China Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 93: China Health Expenditure, (% of GDP), 2014-2017 
Figure 94: China Population Ages 65 and Above (% of total), 2015-2019
Figure 95: China Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 96: China Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 97: China Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 98: China Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 99: India Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 100: India Health Expenditure, (% of GDP), 2014-2017 
Figure 101: India Population Ages 65 and Above (% of total), 2015-2019
Figure 102: India Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 103: India Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 104: India Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 105: India Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 106: South Korea Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 107: South Korea Health Expenditure, (% of GDP), 2014-2017 
Figure 108: South Korea Population Ages 65 and Above (% of total), 2015-2019
Figure 109: South Korea Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 110: South Korea Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 111: South Korea Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 112: South Korea Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 113: Japan Psoriasis Treatment Market Size, By Value, 2015-2025 (USD Million)
Figure 114: Japan Health Expenditure, (% of GDP), 2014-2017 
Figure 115: Japan Population Ages 65 and Above (% of total), 2015-2019
Figure 116: Japan Prevalence of Psoriasis, 2014-2017 (In Thousands)
Figure 117: Japan Research and Development Expenditure, 2015-2018 (In % of GDP)
Figure 118: Japan Psoriasis Market- By Type, By Value (USD Million), 2015-2025
Figure 119: Japan Psoriasis Market- By Treatment Method, By Value (USD Million), 2015-2025
Figure 120: Market Attractiveness Chart of Global Psoriasis Treatment Market - By Type (Year-2025)
Figure 121: Market Attractiveness Chart of Global Psoriasis Market - By Treatment Method (Year-2025)
Figure 122: Market Attractiveness Chart of Global Psoriasis Treatment Market - By Region, By Value, (Year-2025)
Figure 123: Market Share of global leaders in Psoriasis, By Company (%)  (2019)
Figure 124: UCB, Revenue, 2015-2019 (USD Millions)
Figure 125: UCB, Revenue, By Segment, 2019 (in %)
Figure 126: UCB, Profit,  2015- 2019(USD Million)
Figure 127: UCB, Revenue, By Region, 2019 (in %)
Figure 128: Sun Pharmaceutical Industries LTD, Revenue, 2015-2019 (USD Millions)
Figure 129: Sun Pharmaceutical Industries LTD, Revenue, By Geography Segment, 2019 (in %)
Figure 130: Sun Pharmaceutical Industries LTD, Profit,  2015- 2019(USD Million)
Figure 131: Boehringer Ingelheim, Net sales, 2015-2019 (USD Millions)
Figure 132: Boehringer Ingelheim, Revenue, By Business Segment, 2019 (in %)
Figure 133: Boehringer Ingelheim, Profit,  2015- 2019(USD Million)
Figure 134: Boehringer Ingelheim, Revenue, By Geography Segment, 2019 (in %)
Figure 135: Almirall, Net sales, 2015-2019 (USD Millions)
Figure 136: Almirall, Revenue, By Geography Segment, 2019 (in %)
Figure 137: Almirall, Net Income/Loss,  2015- 2019(USD Million)
Figure 138: Bausch Health, Revenue, 2015-2019 (USD Millions)
Figure 139: Bausch Health, Revenue, By Segment, 2019 (in %)
Figure 140: Bausch Health, Net Income/ Loss,  2015- 2019(USD Million)
Figure 141: Bausch Health, Revenue, By Region, 2019 (in %)
Figure 142: Bausch Health, Revenue, By Type, 2019 (in %)
Figure 143: Abbvie Inc , Net sales, 2015-2019 (USD Millions)
Figure 144: Abbvie Inc , Revenue, By Pharmaceuticals Product, 2019 (in %)
Figure 145: Abbvie Inc, Net Earnings,  2015- 2019(USD Million)
Figure 146: Abbvie Inc , Revenue, By Geography Segment, 2019 (in %)
Figure 147: Eli Lilly and Company, Net sales, 2015-2019 (USD Millions)
Figure 148: Eli Lilly and Company, Revenue, By Pharmaceuticals Product, 2019 (in %)
Figure 149: Eli Lilly and Company, Net Earnings,  2015- 2019(USD Million)
Figure 150: Eli Lilly and Company, Revenue, By Geography, 2019 (in %)
Figure 151:  Pfizer Inc., Revenue, 2015-2019 (USD Millions)
Figure 152: Pfizer Inc., Revenue, By Geography Segment, 2019 (in %)
Figure 153: Pfizer Inc., Profit,  2015- 2019(USD Million)
Figure 154: Amgen Inc., Revenue, 2015-2019 (USD Millions)
Figure 155: Amgen Inc., Revenue, By Segment, 2019 (in %)
Figure 156: Amgen Inc., Net Income/ Loss,  2015- 2019(USD Million)
Figure 157: Amgen Inc., Revenue, By Geography, 2019 (in %)
Figure 158: Johnson & Johnson, Net Sales, 2014 - 2019 (In USD Million)
Figure 159: Johnson & Johnson, Net Profit, 2014 - 2019 (In USD Million)
Figure 160: Johnson & Johnson, Net Sales, By Geographic Region, 2019 (In %)
Figure 161: Johnson & Johnson, Sales Revenue, By Business Segment, 2019 (In %)
Figure 162: Johnson & Johnson, Net Sales, By Consumer Business Segment, 2019 (In %)

List of Tables

Table A: Treatment options for Psoriasis
Table B: Prominent Psoriasis companies operated in North America Market
Table C: Prominent Psoriasis companies operating in Europe Market
Table D: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table E: Prominent Psoriasis companies operated in Asia Pacific Market
Table F: List of Drugs in Phase I
Table G: List of Drugs in Phase II
Table H: List of Drugs in Phase III
Table I: List of Drugs in FDA- Approved

One can also purchase any particular sections from this report. Please send us an email to info@azothanalytics.com with your order details.
 
 
 
 
 Latest Market Research Reports